Biomarkers for depression: recent insights, current challenges and future prospects

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,501 · see citing works

From inflammation to sickness and depression: when the immune system subjugates the brain

Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · see citing works

Research domain criteria (RDoC): toward a new classification framework for research on mental disorders

Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067 · see citing works

A Meta-Analysis of Cytokines in Major Depression

Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · see citing works

The role of inflammation in depression: from evolutionary imperative to modern treatment target

Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · see citing works

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · see citing works

No health without mental health

Prince, M. J., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M. R., & Rahman, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61238-0 · Cited by 3,835 · see citing works

Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis

(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010 · see citing works

Cytokines sing the blues: inflammation and the pathogenesis of depression

Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009 · see citing works

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766 · see citing works

Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative

Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627 · see citing works

Gut–brain axis: How the microbiome influences anxiety and depression

Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460 · see citing works

Depression and poor glycemic control: a meta-analytic review of the literature.

Lustman, P. J., Anderson, R. J., Freedland, K. E., de Groot, M., Carney, R. M., & Clouse, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.934 · Cited by 1,854 · see citing works

Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms

Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · see citing works

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression: The Role of Baseline Inflammatory Biomarkers

Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · see citing works

Challenges of Big Data analysis

Fan, J., Han, F., & Liu, H. (2014) · National Science Review · doi:10.1093/nsr/nwt032 · Cited by 1,482 · see citing works

Visceral fat adipokine secretion is associated with systemic inflammation in obese humans

Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., & Klein, S. (2007) · Diabetes · doi:10.2337/db06-1656 · Cited by 1,417 · see citing works

Diagnosis and definition of treatment-resistant depression

Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380 · see citing works

The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis

Steptoe, A., Hamer, M., & Chida, Y. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.03.011 · Cited by 1,278 · see citing works

Childhood maltreatment predicts adult inflammation in a life-course study

Danese, A., Pariante, C. M., Caspi, A., Taylor, A., & Poulton, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610362104 · Cited by 1,264 · see citing works

Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications

Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232 · see citing works

Adverse Childhood Experiences and Adult Risk Factors for Age-Related Disease: Depression, Inflammation, and Clustering of Metabolic Risk Markers

Danese, A., Moffitt, T. E., Harrington, H., Milne, B. J., Polanczyk, G., Pariante, C. M., Poulton, R., & Caspi, A. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.214 · Cited by 1,165 · see citing works

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder

Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129 · see citing works

Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research

Stetler, C., & Miller, G. E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31820ad12b · Cited by 1,123 · see citing works

A mega-analysis of genome-wide association studies for major depressive disorder

Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke, S., Wray, N. R., Lewis, C. M., Hamilton, S. P., Weissman, M. M., Breen, G., Byrne, E. M., Blackwood, D. H. R., Boomsma, D. I., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.21 · Cited by 1,120 · see citing works

A Review of Accelerometry-Based Wearable Motion Detectors for Physical Activity Monitoring

Yang, C.-C., & Hsu, Y.-L. (2010) · Sensors · doi:10.3390/s100807772 · Cited by 1,058 · see citing works

Evidence for an immune response in major depression: A review and hypothesis

Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003 · see citing works

Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?

Kapur, S., Phillips, A. G., & Insel, T. R. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.105 · Cited by 980 · see citing works

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972 · see citing works

Interleukin (IL)-6, Tumour Necrosis Factor Alpha (TNF-α) and Soluble Interleukin-2 Receptors (SIL-2R) Are Elevated in Patients with Major Depressive Disorder: A Meta-Analysis and Meta-Regression

Liu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948 · see citing works

Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder.

Hirschfeld, R. M. A., Lewis, L., & Vornik, L. A. (2003) · PubMed · Cited by 943 · see citing works

Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects: A Systematic Review and Meta-analysis of Randomized Clinical Trials

Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941 · see citing works

The macrophage theory of depression

Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931 · see citing works

HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition

Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., & Schatzberg, A. F. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.120 · Cited by 922 · see citing works

The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis

Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914 · see citing works

Altered Gene Expression of Brain-Derived Neurotrophic Factor and Receptor Tyrosine Kinase B in Postmortem Brain of Suicide Subjects

Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875 · see citing works

Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile

Penninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839 · see citing works

Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma

Nemeroff, C. B., Heim, C. M., Thase, M. E., Klein, D. N., Rush, A. J., Schatzberg, A. F., Ninan, P. T., McCullough, J. P., Weiss, P. M., Dunner, D. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336126100 · Cited by 829 · see citing works

Bidirectional Association Between Depression and Metabolic Syndrome

Pan, A., Keum, N., Okereke, O. I., Sun, Q., Kivimaki, M., Rubin, R. R., & Hu, F. B. (2012) · Diabetes Care · doi:10.2337/dc11-2055 · Cited by 772 · see citing works

The correlative triad among aging, dopamine, and cognition: Current status and future prospects

Bäckman, L., Nyberg, L. H., Lindenberger, U., Li, S., & Farde, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.06.005 · Cited by 761 · see citing works

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759 · see citing works

Cytokine Production and Treatment Response in Major Depressive Disorder

Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735 · see citing works

The microfluidics of the eccrine sweat gland, including biomarker partitioning, transport, and biosensing implications

Sonner, Z., Wilder, E., Heikenfeld, J., Kasting, G., Beyette, F., Swaile, D., Sherman, F., Joyce, J., Hagen, J., Kelley-Loughnane, N., et al. (2015) · Biomicrofluidics · doi:10.1063/1.4921039 · Cited by 724 · see citing works

Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents

Duman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714 · see citing works

Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)

Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.105 · Cited by 702 · see citing works

The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression

Maes, M., Leonard, B. E., Myint, A. M., Kubera, M., & Verkerk, R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.017 · Cited by 700 · see citing works

Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression

Lamers, F., Vogelzangs, N., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.144 · Cited by 691 · see citing works

Depressive disorders and immunity: 20 years of progress and discovery

Irwin, M. R., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.01.010 · Cited by 676 · see citing works

Inflammation and clinical response to treatment in depression: A meta-analysis

Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.007 · Cited by 666 · see citing works

What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression

Gaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1439 · Cited by 661 · see citing works

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

Maes, M., Berk, M., Goehler, L., Song, C., Anderson, G., Gałecki, P., & Leonard, B. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-66 · Cited by 629 · see citing works

The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?

Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592 · see citing works

The Link between Thyroid Function and Depression

Hage, M. P., & Azar, S. T. (2012) · Journal of Thyroid Research · doi:10.1155/2012/590648 · Cited by 549 · see citing works

Is depression an inflammatory disorder?

Raison, C. L., & Miller, A. H. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0232-0 · Cited by 524 · see citing works

Neurocognitive impairment in drug-free patients with major depressive disorder

Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.214 · Cited by 519 · see citing works

Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology

Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 477 · see citing works

Toward understanding how early-life stress reprograms cognitive and emotional brain networks

Chen, Y., & Baram, T. Z. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.181 · Cited by 474 · see citing works

Neuroendocrine aspects of hypercortisolism in major depression

Parker, K. J., Schatzberg, A. F., & Lyons, D. M. (2003) · Hormones and Behavior · doi:10.1016/s0018-506x(02)00016-8 · Cited by 455 · see citing works

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment

Lee, B.-H., & Kim, Y. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.4.231 · Cited by 447 · see citing works

Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population

Srikanthan, K., Feyh, A., Visweshwar, H., Shapiro, J. I., & Sodhi, K. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.13800 · Cited by 443 · see citing works

Serum and plasma BDNF levels in major depression: A replication study and meta-analyses

Bocchio-Chiavetto, L., Bagnardi, V., Zanardini, R., Molteni, R., Gabriela Nielsen, M., Placentino, A., Giovannini, C., Rillosi, L., Ventriglia, M., Riva, M. A., et al. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003611319 · Cited by 435 · see citing works

NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice

Walker, A. K., Budac, D. P., Bisulco, S., Lee, A. W., Smith, R. A., Beenders, B., Kelley, K. W., & Dantzer, R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.71 · Cited by 432 · see citing works

The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery

Dahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424 · see citing works

An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline

Uher, R., Tansey, K. E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010094 · Cited by 418 · see citing works

Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways

Shishehbor, M. H., Brennan, M., Aviles, R. J., Fu, X., Penn, M. S., Sprecher, D. L., & Hazen, S. L. (2003) · Circulation · doi:10.1161/01.cir.0000080895.05158.8b · Cited by 405 · see citing works

Predictive neural biomarkers of clinical response in depression. a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies

Fu, C. H. Y., Steiner, H., & Costafreda, S. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.008 · Cited by 399 · see citing works

Depression: an inflammatory illness?: Figure 1

Krishnadas, R., & Cavanagh, J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301779 · Cited by 392 · see citing works

Reproductive hormone sensitivity and risk for depression across the female life cycle: A continuum of vulnerability?

Soares, C. N., & Zitek, B. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0831 · Cited by 388 · see citing works

The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters

Aagaard, K., Petrosino, J., Keitel, W., Watson, M., Katancik, J., Garcia, N., Patel, S., Cutting, M., Madden, T., Hamilton, H., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-220806 · Cited by 383 · see citing works

A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers

Lopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.017 · Cited by 371 · see citing works

A Systematic Review and Meta-analysis of the Association Between Depression and Insulin Resistance

Kan, C., Silva, N., Golden, S. H., Rajala, U., Timonen, M., Stahl, D. R., & Ismail, K. (2013) · Diabetes Care · doi:10.2337/dc12-1442 · Cited by 363 · see citing works

Functional metabolomics: from biomarker discovery to metabolome reprogramming

Peng, B., Li, H., & Peng, X. (2015) · Protein & Cell · doi:10.1007/s13238-015-0185-x · Cited by 356 · see citing works

Brain-derived neurotrophic factor in mood disorders and antidepressant treatments

Castrén, E., & Kojima, M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.010 · Cited by 337 · see citing works

The heterogeneity of “major depression”

GOLDBERG, D. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00061.x · Cited by 335 · see citing works

Association of depressive disorders, depression characteristics and antidepressant medication with inflammation

Vogelzangs, N., Duivis, H. E., Beekman, A. T. F., Kluft, C., Neuteboom, J., Hoogendijk, W., Smit, J. H., de Jonge, P., & Penninx, B. W. J. H. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.8 · Cited by 323 · see citing works

Synaptic plasticity in depression: Molecular, cellular and functional correlates

Marsden, W. N. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.012 · Cited by 315 · see citing works

Serotonin receptors involved in antidepressant effects

Artigas, F. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.006 · Cited by 311 · see citing works

Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways.

Maes, M. H. J., Kubera, M., Obuchowiczwa, E., Goehler, L. E., & Brzeszcz, J. (2011) · PubMed · Cited by 303 · see citing works

The leptin hypothesis of depression: a potential link between mood disorders and obesity?

Lu, X.-Y. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.010 · Cited by 303 · see citing works

Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal

Hanson, N. D., Owens, M. J., & Nemeroff, C. B. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.220 · Cited by 302 · see citing works

Biological embedding of stress through inflammation processes in childhood

Danese, A., Caspi, A., Williams, B., Ambler, A., Sugden, K., Mika, J., Werts, H., Freeman, J., Pariante, C. M., Moffitt, T. E., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.5 · Cited by 301 · see citing works

What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies

Fekadu, A., Wooderson, S. C., Markopoulo, K., Donaldson, C., Papadopoulos, A. S., & Cleare, A. J. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.014 · Cited by 299 · see citing works

Polymorphisms in Inflammation-Related Genes Are Associated with Susceptibility to Major Depression and Antidepressant Response

Wong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295 · see citing works

Cognitive Behavioral Therapy for Mood Disorders: Efficacy, Moderators and Mediators

Driessen, E., & Hollon, S. D. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.005 · Cited by 291 · see citing works

A detailed examination of cytokine abnormalities in Major Depressive Disorder

Simon, N. M., McNamara, K., Chow, C. W., Maser, R. S., Papakostas, G. I., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K. K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.004 · Cited by 286 · see citing works

Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging

Lindqvist, D., Epel, E. S., Mellon, S. H., Penninx, B. W., Révész, D., Verhoeven, J. E., Reus, V. I., Lin, J., Mahan, L., Hough, C. M., et al. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.007 · Cited by 285 · see citing works

A Multidimensional Tool to Quantify Treatment Resistance in Depression

Fekadu, A., Wooderson, S. C., Donaldson, C., Markopoulou, K., Masterson, B., Poon, L., & Cleare, A. J. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04309 · Cited by 283 · see citing works

Neurobiological effects of exercise on major depressive disorder: A systematic review

Schuch, F. B., Deslandes, A. C., Stubbs, B., Gosmann, N. P., Silva, C. T. B. D., & Fleck, M. P. D. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.012 · Cited by 279 · see citing works

A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity

Hiles, S. A., Baker, A. L., de Malmanche, T., & Attia, J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.001 · Cited by 274 · see citing works

Inhibition of GSK3 by lithium, from single molecules to signaling networks

Freland, L., & Beaulieu, J. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00014 · Cited by 269 · see citing works

A psychoneuroimmunological review on cytokines involved in antidepressant treatment response

Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1103 · Cited by 240 · see citing works

The common inflammatory etiology of depression and cognitive impairment: a therapeutic target

Allison, D. J., & Ditor, D. S. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0151-1 · Cited by 234 · see citing works

Depressive symptoms and metabolic syndrome: is inflammation the underlying link?

Capuron, L., Su, S., Miller, A. H., Bremner, J. D., Goldberg, J., Vogt, G. J., Maisano, C., Jones, L., Murrah, N. V., & Vaccarino, V. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.019 · Cited by 219 · see citing works

Multi-omic data integration and analysis using systems genomics approaches: methods and applications in animal production, health and welfare

Suravajhala, P., Kogelman, L. J. A., & Kadarmideen, H. N. (2016) · Genetics Selection Evolution · doi:10.1186/s12711-016-0217-x · Cited by 219 · see citing works

Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis

Hiles, S. A., Baker, A., de Malmanche, T., & Attia, J. (2012) · Psychological Medicine · doi:10.1017/s0033291712000128 · Cited by 218 · see citing works

Polygenic interactions with environmental adversity in the aetiology of major depressive disorder

Mullins, N., Power, R. A., Fisher, H. L., Hanscombe, K. B., Euesden, J., Iniesta, R., Levinson, D. F., Weissman, M. M., Potash, J. B., Shi, J., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715002172 · Cited by 210 · see citing works

The 5-HT1A receptor in Major Depressive Disorder

Kaufman, J., DeLorenzo, C., Choudhury, S., & Parsey, R. V. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.039 · Cited by 207 · see citing works

Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later

Miller, G. E., Rohleder, N., & Cole, S. W. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318190d7de · Cited by 197 · see citing works

A meta-analysis of chemokines in major depression

Eyre, H. A., Air, T., Pradhan, A., Johnston, J., Lavretsky, H., Stuart, M. J., & Baune, B. T. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.006 · Cited by 188 · see citing works

The association between depressive symptoms, cognitive function, and inflammation in major depression

Krogh, J., Benros, M. E., Jørgensen, M. B., Vesterager, L., Elfving, B., & Nordentoft, M. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.08.014 · Cited by 185 · see citing works

Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: The prospective Sydney Memory and Aging Study

Baune, B., Smith, E., Reppermund, S., Air, T., Samaras, K., Lux, O., Brodaty, H., Sachdev, P. S., & Trollor, J. N. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.02.006 · Cited by 184 · see citing works

Assessment of a Multi-Assay, Serum-Based Biological Diagnostic Test for Major Depressive Disorder: A Pilot and Replication Study

Papakostas, G. I., Shelton, R. C., Kinrys, G., Henry, M. E., Bakow, B. R., Lipkin, S. H., Pi, B., Thurmond, L., & Bilello, J. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.166 · Cited by 180 · see citing works

Studying depression using imaging and machine learning methods

Patel, M. J., Khalaf, A. M., & Aizenstein, H. J. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.11.003 · Cited by 179 · see citing works

The impact of childhood adversity on suicidality and clinical course in treatment-resistant depression

Tunnard, C., Rane, L. J., Wooderson, S. C., Markopoulou, K., Poon, L., Fekadu, A., Juruena, M. F., & Cleare, A. J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.037 · Cited by 176 · see citing works

Biological Aspects of the Link between Smoking and Depression

Quattrocki, E., Baird, A., & Yurgelun-Todd, D. (2000) · Harvard Review of Psychiatry · doi:10.1080/hrp_8.3.99 · Cited by 176 · see citing works

Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial

Arnow, B. A., Blasey, C., Williams, L. M., Palmer, D. M., Rekshan, W., Schatzberg, A. F., Etkin, A., Kulkarni, J., Luther, J. F., & Rush, A. J. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14020181 · Cited by 175 · see citing works

Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications

Rosenblat, J. D., Brietzke, E., Mansur, R. B., Maruschak, N. A., Lee, Y., & McIntyre, R. S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.058 · Cited by 172 · see citing works

The role of interleukin (IL)‐17 in anxiety and depression of patients with rheumatoid arthritis

Yang, L. I. U., Ho, R., & Mak, A. (2011) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2011.01673.x · Cited by 167 · see citing works

Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system

Carvalho, L. A., Torre, J. P., Papadopoulos, A. S., Poon, L., Juruena, M. F., Markopoulou, K., Cleare, A. J., & Pariante, C. M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.036 · Cited by 167 · see citing works

Antiglucocorticoid treatment of depression: double-blind ketoconazole

Wolkowitz, O. M., Reus, V. I., Chan, T., Manfredi, F., Raum, W. J., Johnson, R., & Canick, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00267-4 · Cited by 165 · see citing works

The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models

Baune, B. T., Stuart, M. J., Gilmour, A., Wersching, H., Heindel, W. L., Arolt, V., & Berger, K. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.18 · Cited by 159 · see citing works

Genetic Determinants of Depression: Recent Findings and Future Directions

Dunn, E. C., Brown, R. C., Dai, Y., Rosand, J., Nugent, N. R., Amstadter, A. B., & Smoller, J. W. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000054 · Cited by 158 · see citing works

Role of inflammatory cytokines in depression: Focus on interleukin-1β

Farooq, R. K., Asghar, K., Kanwal, S., & Zulqernain, A. (2016) · Biomedical Reports · doi:10.3892/br.2016.807 · Cited by 151 · see citing works

VEGF as a potential target for therapeutic intervention in depression

Warner‐Schmidt, J. L., & Duman, R. S. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.013 · Cited by 150 · see citing works

The Efficacy of Omega-3 Supplementation for Major Depression

Lespérance, F., Frasure‐Smith, N., St-André, E., Turecki, G., Lespérance, P., & Wisniewski, S. R. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m05966blu · Cited by 149 · see citing works

Plasma lipidomics reveals potential lipid markers of major depressive disorder

Liu, X., Li, J., Zheng, P., Zhao, X., Zhou, C., Hu, C., Hou, X., Wang, H., Xie, P., & Xu, G. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9768-5 · Cited by 148 · see citing works

Risk factors for treatment resistance in unipolar depression: A systematic review

Bennabi, D., Aouizerate, B., El‐Hage, W., Doumy, O., Molière, F., Courtet, P., Nieto, I., Bellivier, F., Bubrovsky, M., Vaïva, G., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.020 · Cited by 142 · see citing works

Upregulation of blood proBDNF and its receptors in major depression

Zhou, L., Xiong, J., Lim, Y. P., Ruan, Y., Huang, C., Zhu, Y., Zhong, J., Xiao, Z., & Zhou, X. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.03.002 · Cited by 142 · see citing works

Variations in Circulating Cytokine Levels during 52 Week Course of Treatment with SSRI for Major Depressive Disorder

Hernández, M. E., Mendieta, D., Martínez-Fong, D., Loría, F., Moreno, J., Estrada, I., Bojalil, R., & Pavón, L. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.08.001 · Cited by 140 · see citing works

Inflammatory Biomarkers as Differential Predictors of Antidepressant Response

Hashimoto, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047796 · Cited by 138 · see citing works

Adipokines as emerging depression biomarkers: A systematic review and meta-analysis

Carvalho, A. F., Rocha, D. Q. C., McIntyre, R. S., Mesquita, L. M., Köhler, C. A., Hyphantis, T. N., Sales, P. M. G., Machado‐Vieira, R., & Berk, M. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.08.002 · Cited by 138 · see citing works

The relationship between cortisol, stress and psychiatric illness: New insights using hair analysis

Herane Vives, A., De Angel, V., Papadopoulos, A., Strawbridge, R., Wise, T., Young, A. H., Arnone, D., & Cleare, A. J. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.08.007 · Cited by 129 · see citing works

Modulation of the mineralocorticoid receptor as add-on treatment in depression: A randomized, double-blind, placebo-controlled proof-of-concept study

Otte, C., Hinkelmann, K., Moritz, S., Yassouridis, A., Jahn, H., Wiedemann, K., & Kellner, M. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.10.006 · Cited by 129 · see citing works

The ratio of cortisol/DHEA in treatment resistant depression

Markopoulou, K., Papadopoulos, A. S., Juruena, M. F., Poon, L., Pariante, C. M., & Cleare, A. J. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.08.004 · Cited by 129 · see citing works

Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients

Cattaneo, A., Ferrari, C., Uher, R., Bocchio‐Chiavetto, L., Riva, M. A., & Pariante, C. M. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw045 · Cited by 129 · see citing works

Risk factors for the bipolar and depression spectra

Angst, J., Gamma, A., & Endrass, J. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s418.4.x · Cited by 127 · see citing works

The Maudsley Staging Method for Treatment-Resistant Depression: Prediction of Longer-Term Outcome and Persistence of Symptoms

Fekadu, A., Wooderson, S. C., Markopoulou, K., & Cleare, A. J. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04728 · Cited by 125 · see citing works

Treatment response and cognitive impairment in major depression: Association with C-reactive protein

Chang, H. H., Lee, I. H., Gean, P. W., Lee, S.-Y., Chi, M. H., Yang, Y. K., Lu, R.-B., & Chen, P. S. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.239 · Cited by 120 · see citing works

Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale

Jacobsen, J. P. R., Krystal, A. D., Krishnan, K. R. R., & Caron, M. G. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.09.001 · Cited by 120 · see citing works

The pharmacology of effort-related choice behavior: Dopamine, depression, and individual differences

Salamone, J. D., Correa, M., Yohn, S. E., López‐Cruz, L., Miguel, N. S., & Alatorre, L. F. (2016) · Behavioural Processes · doi:10.1016/j.beproc.2016.02.008 · Cited by 117 · see citing works

Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression

Diniz, B. S., Sibille, E., Ding, Y., Tseng, G., Aizenstein, H. J., Lotrich, F., Becker, J. T., Lopez, O. L., Lotze, M. T., Klunk, W. E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.76 · Cited by 116 · see citing works

Biochemical markers subtyping major depressive disorder

Kunugi, H., Hori, H., & Ogawa, S. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12299 · Cited by 115 · see citing works

Cortisol as a predictor of psychological therapy response in depressive disorders: Systematic review and meta-analysis

Fischer, S., Strawbridge, R., Vives, A. H., & Cleare, A. J. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.180653 · Cited by 112 · see citing works

Sustained Low-Grade Pro-inflammatory State in Unmedicated, Remitted Women with Major Depressive Disorder as Evidenced by Elevated Serum Levels of the Acute Phase Proteins C-reactive Protein and Serum Amyloid A

Kling, M. A., Alesci, S., Csako, G., Costello, R., Luckenbaugh, D. A., Bonne, O., Duncko, R., Drevets, W. C., Manji, H. K., Charney, D. S., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.033 · Cited by 111 · see citing works

Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin

Horowitz, M. A., & Zunszain, P. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12781 · Cited by 110 · see citing works

Ghrelin in psychiatric disorders – A review

Wittekind, D. A., & Kluge, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.11.013 · Cited by 107 · see citing works

Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients

Stelzhammer, V., Haenisch, F., Chan, M. K., Cooper, J. D., Steiner, J., Steeb, H., Martins-de-Souza, D., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000819 · Cited by 105 · see citing works

Diagnostic and therapeutic utility of neuroimaging in depression: an overview

Arnone, D., Wise, T., Cleare, A. J., Young, A. H., & Herane-Vives, A. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s50156 · Cited by 104 · see citing works

Fusing Data Mining, Machine Learning and Traditional Statistics to Detect Biomarkers Associated with Depression

Dipnall, J. F., Pasco, J. A., Berk, M., Williams, L. J., Dodd, S., Jacka, F. N., & Meyer, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148195 · Cited by 103 · see citing works

Decreased glial cell line-derived neurotrophic factor levels in patients with depression: A meta-analytic study

Lin, P., & Tseng, P. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.004 · Cited by 95 · see citing works

A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates

Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95 · see citing works

Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide

Isung, J., Mobarrez, F., Nordström, P., Åsberg, M., & Jokinen, J. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.624549 · Cited by 94 · see citing works

High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania

Huang, T.-L., & Lin, F.-C. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.09.010 · Cited by 90 · see citing works

A Neurobiological Hypothesis of Treatment-Resistant Depression – Mechanisms for Selective Serotonin Reuptake Inhibitor Non-Efficacy

Coplan, J. D., Gopinath, S., Abdallah, C. G., & Berry, B. R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00189 · Cited by 90 · see citing works

Treatment strategies to improve and sustain remission in major depressive disorder

Trivedi, M. H., & Daly, E. J. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/mhtrivedi · Cited by 89 · see citing works

Subclinical hypothyroidism, mood, and cognition in older adults: a review

Joffe, R. T., Pearce, E. N., Hennessey, J. V., Ryan, J. J., & Stern, R. A. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3796 · Cited by 88 · see citing works

CSF biomarkers in suicide attempters – a principal component analysis

Lindqvist, D., Janelidze, S., Erhardt, S., Träskman‐Bendz, L., Engström, G., & Brundin, L. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01655.x · Cited by 86 · see citing works

Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis

Carvalho, A. F., Köhler, C. A., McIntyre, R. S., Knöchel, C., Brunoni, A. R., Thase, M. E., Quevedo, J., Fernandes, B. S., & Berk, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.002 · Cited by 86 · see citing works

Predictors of response to antidepressants

Nierenberg, A. A. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00105-3 · Cited by 84 · see citing works

Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews

Mercier, A., Aubin-Auger, I., Lebeau, J., Schuers, M., Boulet, P., Hermil, J.-L., Royen, P. V., & Peremans, L. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-55 · Cited by 81 · see citing works

Prediction of longer-term outcome of treatment-resistant depression in tertiary care

Fekadu, A., Rane, L. J., Wooderson, S. C., Markopoulou, K., Poon, L., & Cleare, A. J. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.102665 · Cited by 77 · see citing works

Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response

Powell, T. R., Schalkwyk, L. C., Heffernan, A. L., Breen, G. D., Lawrence, T., Price, T., FARMER, A. E., Aitchison, K. J., Craig, I., Danese, A., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.009 · Cited by 75 · see citing works

Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression

Eyre, H. A., Lavretsky, H., Kartika, J., Qassim, A., & Baune, B. T. (2016) · Pharmacopsychiatry · doi:10.1055/s-0042-103159 · Cited by 75 · see citing works

Discriminating Between Bipolar Disorder and Major Depressive Disorder

Vöhringer, P. A., & Perlis, R. H. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.10.001 · Cited by 74 · see citing works

Gene expression biomarkers of response to citalopram treatment in major depressive disorder

Mamdani, F., Berlim, M. T., Beaulieu, M.-M., Labbe, A., Mérette, C., & Turecki, G. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.12 · Cited by 72 · see citing works

Treatment strategies to improve and sustain remission in major depressive disorder.

Trivedi, M. H., & Daly, E. (2008) · Europe PMC (PubMed Central) · Cited by 70 · see citing works

A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain

Popa, D., Cerdan, J., Repérant, C., Guiard, B. P., Guilloux, J., David, D. J. P., & Gardier, A. M. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.11.037 · Cited by 69 · see citing works

Altered Chemokine Levels in the Cerebrospinal Fluid and Plasma of Suicide Attempters

Janelidze, S., Ventorp, F., Erhardt, S., Hansson, O., Minthon, L., Flax, J., Samuelsson, M., Traskman-Bendz, L., & Brundin, L. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.010 · Cited by 69 · see citing works

Possible contribution of IGF-1 to depressive disorder

Szczęsny, E., Ślusarczyk, J., Głombik, K., Budziszewska, B., Kubera, M., Lasoń, W., & Basta-Kaim, A. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71523-8 · Cited by 68 · see citing works

Superposição entre depressão atípica, doença afetiva sazonal e síndrome da fadiga crônica

Juruena, M. F., & Cleare, A. J. (2007) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462007000500005 · Cited by 67 · see citing works

Increased levels of vascular endothelial growth factor in patients with major depressive disorder: A meta-analysis

Tseng, P., Cheng, Y., Chen, Y., Wu, C.-K., & Lin, P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.001 · Cited by 63 · see citing works

Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review

Tseng, P., Lin, P., Tu, K.-Y., Cheng, Y., Wu, C.-K., & Chen, Y. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s81432 · Cited by 63 · see citing works

The macrophage theory of depression

Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90266-2 · Cited by 62 · see citing works

Predictive diagnosis of major depression using NMR-based metabolomics and least-squares support vector machine

Zheng, H. X., Zheng, P., Zhao, L., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.039 · Cited by 60 · see citing works

Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds

Fornaro, M., Rocchi, G., Escelsior, A., Contini, P., & Martino, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.007 · Cited by 59 · see citing works

Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies

Thase, M. E. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/mthase · Cited by 57 · see citing works

Elevation of plasma concentration of adhesion molecules in late‐life depression

Dimopoulos, N. P., Piperi, C., Salonicioti, A., Mitsonis, C., Liappas, I., Lea, R. W., & Kalofoutis, A. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1592 · Cited by 53 · see citing works

Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy

Harley, J., Luty, S., Carter, J., Mulder, R., & Joyce, P. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109102770 · Cited by 53 · see citing works

Neurocognitive Function Following Remission in Major Depressive Disorder: Potential Objective Marker of Response?

Gallagher, P., Robinson, L. J., Gray, J. M., Young, A. H., & Porter, R. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670601057734 · Cited by 52 · see citing works

Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers

Divani, A. A., Luo, X., Datta, Y. H., Flaherty, J. D., & Panoskaltsis‐Mortari, A. (2015) · Mediators of Inflammation · doi:10.1155/2015/379501 · Cited by 51 · see citing works

Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications

Gallagher, P., & Young, A. H. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a811 · Cited by 47 · see citing works

Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial

McAllister-Williams, R. H., Anderson, I. M., Finkelmeyer, A., Gallagher, P., Grunze, H. C. R., Haddad, P. M., Hughes, T., Lloyd, A. J., Mamasoula, C., McColl, E., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00436-8 · Cited by 47 · see citing works

Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls

Tu, K.-Y., Wu, M., Chen, Y., Lin, P., Wang, H., Wu, C.-K., & Tseng, P. (2016) · Medicine · doi:10.1097/md.0000000000002411 · Cited by 46 · see citing works

Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests

Ramsey, J. M., Cooper, J. D., Penninx, B. W. J. H., & Bahn, S. (2016) · Scientific Reports · doi:10.1038/srep26947 · Cited by 45 · see citing works

Neurotrophic factors in depression in response to treatment

Buttenschøn, H. N., Foldager, L., Elfving, B., Poulsen, P. H. P., Uher, R., & Mors, O. N. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.027 · Cited by 44 · see citing works

Fear Biases in Emotional Face Processing Following Childhood Trauma as a Marker of Resilience and Vulnerability to Depression

Suzuki, A., Poon, L., Kumari, V., & Cleare, A. J. (2015) · Child Maltreatment · doi:10.1177/1077559515600781 · Cited by 43 · see citing works

Vascular endothelial growth factor: Potential predictor of treatment response in major depression

Clark-Raymond, A., Meresh, E. S., Hoppensteadt, D., Fareed, J., Sinacore, J. M., Garlenski, B., & Halaris, A. E. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1117655 · Cited by 42 · see citing works

Differential Responses to Psychotherapy Versus Pharmacotherapy in Patients With Chronic Forms of Major Depression and Childhood Trauma

Nemeroff, C. B., Heim, C. M., Thase, M. E., Klein, D. N., Rush, A. J., Schatzberg, A. F., Ninan, P. T., McCullough, J. P., Weiss, P. M., Dünner, D. L., et al. (2005) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.3.1.131 · Cited by 41 · see citing works

Bidirectional Association Between Depression and Metabolic Syndrome A systematic review and meta-analysis of epidemiological studies

Pan, A., Keum, N., Okereke, O., et al. (2012) · UCL Discovery (University College London) · Cited by 40 · see citing works

Plasma Levels of Catecholamine Metabolites Predict the Response to Sulpiride or Fluvoxamine in Major Depression

Ueda, N., Yoshimura, R., Shinkai, K., et al. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-34116 · Cited by 39 · see citing works

Decreased serum fibroblast growth factor - 2 levels in pre- and post-treatment patients with major depressive disorder

Shen, H., Zhang, T., Hong, B., Peng, D., Su, H. L., Lin, Z., Fang, Y., Jiang, K., Liu, X., & Li, H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.035 · Cited by 39 · see citing works

The use of statins for the treatment of depression in patients with acute coronary syndrome

Kim, S. W., Bae, K., Kim, J.-M., Shin, I., Hong, Y. J., Ahn, Y., Jeong, M. H., Berk, M., & Yoon, J. S. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.116 · Cited by 38 · see citing works

Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review

Yoshimura, R., Nakamura, J., Shinkai, K., & Ueda, N. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.008 · Cited by 38 · see citing works

Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers

Jani, B., McLean, G., Nicholl, B. I., Barry, S., Sattar, N. A., Mair, F. S., & Cavanagh, J. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00018 · Cited by 37 · see citing works

Disturbances in Hypothalamic-Pituitary-Adrenal Axis and Immunological Activity Differentiating between Unipolar and Bipolar Depressive Episodes

Becking, K., Spijker, A. T., Hoencamp, E., Penninx, B. W. J. H., Schoevers, R. A., & Boschloo, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133898 · Cited by 35 · see citing works

Chronobiological hypothalamic–pituitary–thyroid axis status and antidepressant outcome in major depression

Duval, F., Mokrani, M., Erb, A., Lopera, F. G., Alexa, C., Proudnikova, X., & Butucaru, I. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.05.005 · Cited by 33 · see citing works

Significantly higher peripheral fibroblast growth factor-2 levels in patients with major depressive disorder

Wu, C.-K., Tseng, P., Chen, Y., Tu, K.-Y., & Lin, P. (2016) · Medicine · doi:10.1097/md.0000000000004563 · Cited by 33 · see citing works

Genetic biomarkers of depression

Tamatam, A., Bawa, A. S., & Khanum, F. (2012) · Indian journal of human genetics · doi:10.4103/0971-6866.96639 · Cited by 31 · see citing works

Big Data in mental health: a challenging fragmented future

Hidalgo‐Mazzei, D., Murru, A., Reinares, M., Vieta, E., & Colom, F. (2016) · World Psychiatry · doi:10.1002/wps.20307 · Cited by 30 · see citing works

No health without mental health

Vladu, C., Novac, A., Preda, A., et al. (2016) · Mental Illness · doi:10.4081/mi.2016.6609 · Cited by 29 · see citing works

Biological Aspects of the Link between Smoking and Depression

Quattrocki, E. (2000) · Harvard Review of Psychiatry · doi:10.1093/hrp/8.3.99 · Cited by 28 · see citing works

Clinical prediction of antidepressant response in mood disorders: Linear multivariate vs. neural network models

Serretti, A., Olgiati, P., Liebman, M., Hu, H., Zhang, Y., Zanardi, R., Colombo, C., & Smeraldi, E. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.07.009 · Cited by 27 · see citing works

Gene expression: Biomarker of antidepressant therapy?

Menke, A. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.825580 · Cited by 25 · see citing works

Detection of bipolar disorder

Young, A. H., & MacPherson, H. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.089128 · Cited by 24 · see citing works

A rest-activity biomarker to predict response to SSRIs in major depressive disorder

McCall, W. V. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.023 · Cited by 24 · see citing works

Soluble Intracellular Adhesion Molecule-1 in Patients with Unipolar or Bipolar Affective Disorders: Results from a Pilot Trial

Schaefer, M., Sarkar, S., Schwarz, M., & Friebe, A. (2016) · Neuropsychobiology · doi:10.1159/000446919 · Cited by 21 · see citing works

Inflammation and treatment resistance in major depression: The perfect storm

Raison, C. L., Felger, J. C., & Miller, A. H. (2013) · ˜The œPsychiatric times · Cited by 21 · see citing works

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder

Atake, K., Yoshimura, R., Hori, H., et al. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.1.37 · Cited by 15 · see citing works

Increased funding needed for mental health research

Kingdon, D., & Wykes, T. (2013) · BMJ · doi:10.1136/bmj.f402 · Cited by 12 · see citing works

Discovery of metabolite biomarkers: flux analysis and reaction-reaction network approach

Li, L., Jiang, H., Qiu, Y., Ching, W., & Vassiliadis, V. S. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-s2-s13 · Cited by 11 · see citing works

Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model-Are we there yet?

Jesulola, E., Micalos, P., & Baguley, I. J. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.025 · Cited by 379 · see citing works

Diagnostic and Predictive Applications of Functional Near-Infrared Spectroscopy for Major Depressive Disorder: A Systematic Review

Ho, C. S. H., Lim, L. J. H., Lim, A. Q., Chan, N. H. C., Tan, R. S., Lee, S. H., & Ho, R. C. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00378 · Cited by 221 · see citing works

Validating a functional near-infrared spectroscopy diagnostic paradigm for Major Depressive Disorder

Husain, S. F., Yu, R., Tang, T.-B., Tam, W. W., Tran, B., Quek, T. T., Hwang, S.-H., Chang, C. W., Ho, C. S., & Ho, R. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-66784-2 · Cited by 213 · see citing works

Peripheral Markers of Depression

Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197 · see citing works

Depressive disorders: treatment failures and poor prognosis over the last 50 years

Blackburn, T. P. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.472 · Cited by 136 · see citing works

Recommendations and future directions for supervised machine learning in psychiatry

Cearns, M., Hahn, T., & Baune, B. T. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0607-2 · Cited by 127 · see citing works

Depression and Obesity: Integrating the Role of Stress, Neuroendocrine Dysfunction and Inflammatory Pathways

Ouakinin, S. R. S., Barreira, D. P., & Gois, C. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00431 · Cited by 125 · see citing works

Circadian depression: A mood disorder phenotype

Carpenter, J. S., Crouse, J. J., Scott, E. M., Naismith, S. L., Wilson, C., Scott, J., Merikangas, K. R., & Hickie, I. B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.045 · Cited by 114 · see citing works

Inflammation as a treatment target in mood disorders: review

Jones, B. D. M., Daskalakis, Z. J., Carvalho, A. F., Strawbridge, R., Young, A. H., Mulsant, B. H., & Husain, M. I. (2020) · BJPsych Open · doi:10.1192/bjo.2020.43 · Cited by 106 · see citing works

Updated Review and Meta-Analysis of Probiotics for the Treatment of Clinical Depression: Adjunctive vs. Stand-Alone Treatment

Nikolova, V., Cleare, A., Young, A., & Stone, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040647 · Cited by 106 · see citing works

Biomarkers of post-covid depression

Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102 · see citing works

Adaptation of Lipid Profiling in Depression Disease and Treatment: A Critical Review

Pinto, B., Conde, T., Domingues, I., & Domingues, M. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042032 · Cited by 51 · see citing works

Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial

McAllister-Williams, R. H., Anderson, I. M., Finkelmeyer, A., Gallagher, P., Grunze, H. C. R., Haddad, P. M., Hughes, T., Lloyd, A. J., Mamasoula, C., McColl, E., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00436-8 · Cited by 47 · see citing works

Rostral anterior cingulate network effective connectivity in depressed adolescents and associations with treatment response in a randomized controlled trial

Jamieson, A. J., Harrison, B. J., Razi, A., & Davey, C. G. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01214-z · Cited by 41 · see citing works

Elevated body temperature is associated with depressive symptoms: results from the TemPredict Study

Mason, A. E., Kasl, P., Soltani, S., Green, A., Hartogensis, W., Dilchert, S., Chowdhary, A., Pandya, L. S., Siwik, C. J., Foster, S. L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-51567-w · Cited by 31 · see citing works

EEG-based spatio-temporal relation signatures for the diagnosis of depression and schizophrenia

Shor, O., Yaniv-Rosenfeld, A., Valevski, A., Weizman, A., Khrennikov, A., & Benninger, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-28009-0 · Cited by 30 · see citing works

The effect of selective serotonin reuptake inhibitors in healthy subjects revisited: A systematic review of the literature.

Knorr, U., Madsen, J. M., & Kessing, L. V. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000264 · Cited by 25 · see citing works

Integrated Single‐Cell RNA‐seq and ATAC‐seq Reveals Heterogeneous Differentiation of CD4 ⁺ Naive T Cell Subsets is Associated with Response to Antidepressant Treatment in Major Depressive Disorder

Sun, Z., Zhang, B., Zhou, J., Luo, Y., Zhu, X., Wang, Y., He, Y., Zheng, P., Zhang, L., Yang, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202308393 · Cited by 20 · see citing works

Advancing depression management through biomarker discovery with a focus on genetic and epigenetic aspects: a comprehensive study on neurobiological, neuroendocrine, metabolic, and inflammatory pathways

Milic, J., Jovic, S., & Sapic, R. (2025) · Genes · doi:10.3390/genes16050487 · Cited by 19 · see citing works

Relationship between CRP and depression: A genetically sensitive study in Sri Lanka

Zavos, H. M. S., Zunszain, P. A., Jayaweera, K., Powell, T. R., Chatzivasileiadou, M., Harber-Aschan, L., Adikari, A., Pannala, G., Siribaddana, S., Badini, I., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.003 · Cited by 15 · see citing works

Inflexible autonomic responses to sadness predict habitual and real-world rumination: A multi-level, multi-wave study

Stange, J. P., Hamilton, J. L., Shepard, R., Wu, J., Fresco, D. M., & Alloy, L. B. (2020) · Biological Psychology · doi:10.1016/j.biopsycho.2020.107886 · Cited by 12 · see citing works

Self-blame-selective hyper-connectivity between anterior temporal and subgenual cortices predicts prognosis in major depressive disorder

Fennema, D., Barker, G. J., O'Daly, O., Duan, S., Carr, E., Goldsmith, K., Young, A. H., Moll, J., & Zahn, R. (2023) · NeuroImage: Clinical · doi:10.1016/j.nicl.2023.103453 · Cited by 7 · see citing works

Combined HTR1A/1B methylation and human functional connectome to recognize patients with MDD

Xu, Z., Gao, C., Tan, T., Jiang, W., Wang, T., Chen, Z., Shen, T., Chen, L., Tang, H., Chen, W., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114842 · Cited by 8 · see citing works

Study protocol on the efficacy of exergames-acceptance and commitment therapy program for the treatment of major depressive disorder: Comparison with acceptance and commitment therapy alone and treatment-as-usual in a multicentre randomised controlled trial

Zhang, B., Deng, H., Ren, J., Legrand, F. D., Ahmad Yusof, H., Zhang, R., & Leong Bin Abdullah, M. F. I. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080315 · Cited by 2 · see citing works

The future of precision medicine: towards a more predictive personalized medicine

Elemento, O. (2020) · Emerging Topics in Life Sciences · doi:10.1042/etls20190197 · Cited by 67 · see citing works

Genomic medicine on the frontier of precision medicine

Hasanzad, M., Sarhangi, N., Naghavi, A., Ghavimehr, E., Khatami, F., Chimeh, S. E., Larijani, B. A., & Meybodi, H. R. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00880-6 · Cited by 21 · see citing works

Precision (personalized) medicine

Walton, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95274-3.00002-6 · Cited by 3 · see citing works

Detecting Personalized Determinants During Drug Treatment from Omics Big Data

Wang, L., Yu, X., Zhang, C., & Zeng, T. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666181106102111 · Cited by 10 · see citing works

TRANSFORMING HEALTHCARE WITH PRECISION MEDICINE: UNVEILING THE FUTURE OF PERSONALIZED TREATMENT

Moulik, A. K., Ratnam, R. S., Sriushaswini, B., et al. (2023) · doi:10.53555/jptcp.v30i17.2885